This HTML5 document contains 147 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n9http://dx.doi.org/10.1023/A:
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33338669
rdf:type
wikibase:Item
schema:description
teaduslik artikkel wetenschappelijk artikel 2001年論文 ২০০১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2001年论文 artigo científico vědecký článek სამეცნიერო სტატია 2001年の論文 vitskapeleg artikkel 2001年论文 2001年論文 article scientific научни чланак vetenskaplig artikel scienca artikolo articol științific artigo científico (publicado na 2001) مقالهٔ علمی article científic 2001年论文 2001年論文 bilimsel makale 2001年论文 научная статья wissenschaftlicher Artikel vitenskapelig artikkel vedecký článok научни чланак 2001 թվականի հուլիսին հրատարակված գիտական հոդված 2001年论文 artikulong pang-agham tieteellinen artikkeli מאמר מדעי мақолаи илмӣ บทความทางวิทยาศาสตร์ 2001 nî lūn-bûn artículu científicu espublizáu en 2001 article scientifique (publié 2001) tudományos cikk 2001年论文 scientific article научна статия naučni članak artigo científico (publicado na 2001) سائنسی مضمون articolo scientifico 2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած наукова стаття, опублікована в липні 2001 2001년 논문 2001年論文 videnskabelig artikel (udgivet 2001) مقالة علمية επιστημονικό άρθρο 2001年論文 bài báo khoa học artikull shkencor мақолаи илмӣ artykuł naukowy mokslinis straipsnis artículo científico publicado en 2001
p:P577
wds:Q33338669-87CDB8BE-A017-4491-8749-DB7A808BA468
wdt:P577
2001-07-01T00:00:00Z
p:P2860
wds:Q33338669-746C1C50-4E4D-4BCD-A04C-AF0C7857D2D0 wds:Q33338669-90FB8090-C5F0-486C-9503-F50B0330C5D8 wds:Q33338669-9CA41BB7-E2B2-4214-B664-16D46344D3C7 wds:Q33338669-A98B1052-93E0-4470-B9A1-17C4FACBE1ED wds:Q33338669-D6F192E7-8CA6-4313-8E8B-0A894C801B63 wds:Q33338669-DB493CA4-910E-4CBF-8FEB-9ADD129B5E29 wds:Q33338669-E3172E12-F9D5-4FA3-BDD3-89B28FBA5207 wds:Q33338669-ED87DCFD-750F-45C9-B733-4C7A0FB741EF wds:Q33338669-FC2C38EE-0176-42F9-8B80-C497AAD0A4E0 wds:Q33338669-FCFAC000-0BE1-44B8-97BA-5AE6F373A235 wds:Q33338669-0EAACC83-D701-4888-9A37-A51FF8E910AF wds:Q33338669-12E7E433-5EE6-45DE-8737-6B427CCC1917 wds:Q33338669-19FF16F5-8455-4386-8C71-EB43A7B09295 wds:Q33338669-1FD95AFE-BD09-4D54-9D31-40DBB8655EA3 wds:Q33338669-20E5A8CD-F0F1-4CFC-BABD-66583099B59C wds:Q33338669-327649FC-954F-4F63-BC61-31B44524D7DE wds:Q33338669-3689C8AF-BD34-40AD-AF34-7A702812D810 wds:Q33338669-3FA0A83A-C03E-4945-A0C4-F825936519B3 wds:Q33338669-4EB79520-7958-4945-A702-4F2CE9A7E760 wds:Q33338669-50AFA4AB-26AD-4283-B497-3A123254ACAD
wdt:P2860
wd:Q68514585 wd:Q40731377 wd:Q33501448 wd:Q71067477 wd:Q33497225 wd:Q28139358 wd:Q44578641 wd:Q73872746 wd:Q33492710 wd:Q41747152 wd:Q29615603 wd:Q33500776 wd:Q74545986 wd:Q33501053 wd:Q72559643 wd:Q33504597 wd:Q33330628 wd:Q43419722 wd:Q33430701 wd:Q33328108
p:P2093
wds:Q33338669-1DA96421-6253-4247-91E6-1D4FC56E8B79 wds:Q33338669-213F415E-8E0B-4F3E-BCE8-4151C4EF9FA9 wds:Q33338669-DC3990F4-E3BD-4334-8365-92C07F95C281 wds:Q33338669-CAF9BF10-BFFD-4A32-B729-FF05C7DB18F2 wds:Q33338669-BCA1BF98-E5CE-4876-ABFA-F0D7B224BB44
wdt:P2093
C Shannon M Drummond H Lau C Crombie A Brooks
rdfs:label
Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features
skos:prefLabel
Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features
schema:name
Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features
p:P50
wds:Q33338669-73A1F348-1E13-453E-B369-13FB8763F28D
wdt:P50
wd:Q37839338
p:P1476
wds:Q33338669-BFCF9B34-A6DF-48E1-B0D0-7C2E9870E516
wdt:P1476
Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features
p:P304
wds:Q33338669-51995E2D-3A42-4DC9-91B9-FF3334FEA96B
wdt:P304
947-952
p:P31
wds:Q33338669-686AFE4D-2A84-43CA-A142-B6EF66DF0C14
wdt:P31
wd:Q13442814
p:P921
wds:Q33338669-762BC684-9A5E-4DA9-855B-F068C3EEEFE6 wds:Q33338669-F653258C-8848-4533-B470-6C7991F97CEC
wdt:P921
wd:Q415588 wd:Q2501186
p:P698
wds:Q33338669-3E49BBB6-51A8-4FBE-BDCF-79C99DFA06B2
wdtn:P698
n11:11521800
wdt:P698
11521800
p:P1433
wds:Q33338669-25A24057-47AD-4FF2-9AD1-326180EF22AB
wdt:P1433
wd:Q326122
p:P433
wds:Q33338669-5D9F440D-94E7-435C-B0C4-8C2E112400AA
p:P478
wds:Q33338669-D07062A9-BDC5-436E-97A8-E219AE9017AB
wdt:P433
7
wdt:P478
12
p:P356
wds:Q33338669-6EDE2E80-1DEB-4219-A767-1DEBFA4C457D
wdtn:P356
n9:1011186104428
wdt:P356
10.1023/A:1011186104428